🟠 Conclusions: The 350% surge in #Allurion's stock reflects strong investor confidence in its clinical study. Success could solidify Allurion's leadership in the obesity treatment market by offering a muscle-preserving, weight-loss solution. 
#obesity #glp1 #weightloss #biotech @FDA $NVO $ALUR $SNY $SAN
#Allurion #obesity #glp1 #weightloss #biotech